MSD’s Keytruda has significantly increased overall survival in patients with lung cancer expressing any level of PD-L1 when used as monotherapy in the first-line setting, potentially significantly increasing the drug’s treatment scope.
News
NHS England backs new innovations for NHS use
NHS England has unveiled the new technologies that are to be fast-tracked into NHS use via the Innovation and Technology Payment Programme (ITP).
NICE u-turn sees Roche’s Tecentriq backed for lung cancer
Following an earlier negative decision NICE is now recommending NHS use of Roche’s immunotherapy Tecentriq for lung cancer.
New US approval for Clovis’ Rubraca
Clovis’ PARP inhibitor Rubraca has won a second US approval, as maintenance treatment for patients with recurrent ovarian cancer.
Incyte/MSD’s immunotherapy combo fails in Phase III
A late stage trial testing Incyte’s epacadostat in combination with MSD’s Keytruda has failed to hit its primary targets in patients with unresectable or metastatic melanoma.
Novartis snaps up AveXis in $8.7bn deal
Novartis is buying US gene therapy group AveXis in a deal valued at $8.7 billion.
Last chance to enter or nominate in Sales Manager of the Year
With hundreds of nominations received so far, and two weeks still left until the closing date, the PharmaTimes Sales Representative of the Year is set be an exciting and highly representative competition.
A fantastic L&D opportunity for sales managers and teams
The PharmaTimes Sales Manager of the Year competition, part of the prestigious annual Sales Awards, is a fantastic learning and development opportunity for sales managers and teams.
PharmaTimes Media announces the launch of the prestigious Sales Awards for 2017
Open to pharma sales representatives and sales managers, candidates in this prominent industry competition are both nominated and judged by healthcare professionals. The PharmaTimes Sales Awards therefore delivers truly meaningful recognition for pharma sales professionals, from the people who matter most: their customers.
HCPs asked to name their Sales Representative of the Year
The PharmaTimes Sales Awards is the ONLY industry wide competition driven by the customer from start to finish…from initial nomination, through to robust assessment, all the way to high quality feedback.
Time is running out to enter Sales Manager of the Year 2016
Compete against your peers in unique, on-the day, competency-based challenges for the chance to win the prestigious Pharma.
Sales Manager of the Year opens for entries
The PharmaTimes Sales Awards is launching for 2016! Delivering meaningful recognition through high quality feedback, the competition recognises and rewards excellence in sales representatives, managers and teams.
Biogen, Samsung Bioepis and Abbvie settle patent dispute
Biogen and Samsung Bioepis have laid to rest a long-running patent wrangle with AbbVie regarding a biosimilar form of the latter’s blockbuster Humira.
US delay for Celltrion’s Rituxan, Herceptin biosimilars
The US Food and Drug Administration has rejected Celltrion’s submissions for biosimilars to Roche drugs Rituxan and Herceptin.
NICE ‘no’ for Roche’s Ocrevus
The National Institute for Health and Care Excellence has turned down NHS funding for Roche’s multiple sclerosis therapy Ocrevus.
